Does MIDOSTAURIN Cause Malignant neoplasm progression? 87 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Malignant neoplasm progression have been filed in association with MIDOSTAURIN (RYDAPT). This represents 2.9% of all adverse event reports for MIDOSTAURIN.
87
Reports of Malignant neoplasm progression with MIDOSTAURIN
2.9%
of all MIDOSTAURIN reports
34
Deaths
16
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MIDOSTAURIN?
Of the 87 reports, 34 (39.1%) resulted in death, 16 (18.4%) required hospitalization, and 2 (2.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIDOSTAURIN. However, 87 reports have been filed with the FAERS database.
What Other Side Effects Does MIDOSTAURIN Cause?
Death (397)
Nausea (252)
Febrile neutropenia (223)
Diarrhoea (194)
Pyrexia (188)
Acute myeloid leukaemia recurrent (171)
Pancytopenia (152)
Vomiting (152)
Drug ineffective (151)
Thrombocytopenia (140)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MIDOSTAURIN Alternatives Have Lower Malignant neoplasm progression Risk?
MIDOSTAURIN vs MIFEPRISTONE
MIDOSTAURIN vs MIGALASTAT
MIDOSTAURIN vs MIGLITOL
MIDOSTAURIN vs MIGLUSTAT
MIDOSTAURIN vs MILNACIPRAN